Nasdaq 100 has been rebalanced with PLTR and MSTR

Palantir Technologies (PLTR), MicroStrategy (MSTR), and Axon Enterprise (AXON)—three of the standout stocks of 2024—are set to join the Nasdaq 100 index on Dec. 23, Nasdaq Inc. announced late Friday.

Exiting the index are Moderna (MRNA), Super Micro Computer (SMCI), and Illumina (ILMN), which rank among the smallest members of the Nasdaq 100. Moderna has seen its stock tumble throughout 2024, while Super Micro has plummeted from its March peak due to significant accounting concerns. Illumina, although up slightly this year, has been on a downtrend since early 2021.

In response to the Nasdaq 100 rebalancing news, SMCI stock dropped sharply late Friday, following a Bloomberg report that the company has enlisted Evercore to assist in raising capital.

The Nasdaq 100 represents the 100 largest non-financial companies and is dominated by tech giants known as the Magnificent Seven: Apple (AAPL), Nvidia (NVDA), Microsoft (MSFT), Alphabet (GOOGL), Amazon (AMZN), Meta Platforms (META), and Tesla (TSLA).

New Nasdaq 100 Entrants:

  • Palantir Technologies: Known for its AI-driven data analytics, Palantir recently switched its listing from the New York Stock Exchange to the Nasdaq in November. Its market cap of $173 billion surpasses many current Nasdaq 100 members.
  • MicroStrategy: While primarily a software company, MicroStrategy is viewed as a leveraged play on Bitcoin, having used stock and debt sales to acquire significant cryptocurrency holdings. Its market cap stands at $82.8 billion.
  • Axon Enterprise: The maker of Taser weapons, body cameras, and digital storage solutions for law enforcement, Axon has surged nearly 150% in 2024.

The rebalancing will prompt mutual funds and ETFs tied to the Nasdaq 100 to adjust their holdings, although the financial impact is smaller compared to changes in the S&P 500 index.

Axon stock is listed on the IBD Leaderboard, while both Palantir and Axon appear on the IBD 50.

Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.